Report Categories
View AllRecent Articles
View All
Aeis Stock Analysis Advanced Energy Industries Inc. Trades Near 332.31 Post Minor 0.15 Dip 20260403
Market Wrap Tech leads gains as consumer sectors lag in mild upturn
How sustainable is Yum Brands YUM profit margins 079 20260507
GNPX Genprex Q1 loss narrower than expected beating estimates by 378 despite zero revenue and shares ticking higher
WSFS WSFS Stock Why Debt Paydown Eye on Rally 20260416
AI Accelerates New Business Formation Led by Gen Z Entrepreneurs Gusto Report
Inflation Projected to Reach 6 in Second Quarter Top Forecasters Warn
Privia PRVA Slips 095 Testing 2187 Support 20260515
ExlService Holdings EXLS Q1 2026 Earnings 058 EPS Surges Past 055 Estimates
Asias TrillionDollar Titans How AILinked Semiconductor Giants Are Fueling and Distorting Record Market Rallies
Olenox Industries OLOX Climbs 1047 Resistance at 587 in Focus 20260517
Xi Jinping Pledges Deeper Market Access for US Firms Amid Trumps Beijing Visit
Neogen Corporation NEOG A Potential SmallCap Turnaround Story
CLBT Q1 2026 Earnings EPS Surpasses Estimates by Nearly 19
PAHC Q1 2026 Earnings EPS Surpasses Expectations Amid Operational Strength
TMobile US Q1 2026 Earnings EPS Surges Past Estimates Despite Modest Stock Decline
KNDI Q2 2024 Earnings Profitability Achieved with EPS of 002
Kyndryl Holdings Inc KD Q1 2026 Earnings Earnings Miss Signals Challenges Ahead
Passage Bio Inc PASG Edges Higher Testing Key Resistance Levels
Everus Construction Group ECG Nears Support as Momentum Weakens
OR Royalties Inc OR Surges 355 Bullish Momentum Tests Key Resistance
Rentokil Initial RTO Slips 109 as Stock Holds Above Key Support Resistance at 3279 in Sight
Bluejay Diagnostics BJDX Edges Higher as Shares Hold Above Key Support
VanEck Avalanche ETF VAVX Slips 29 as Support Levels Are Tested
Alamo Group Inc ALG Climbs 163 as Shares Test Key Resistance Near 160
BXP Inc BXP Holds Steady Near Support as Trading Activity Remains Subdued
Brand Engagement Network Inc BNAI Surges 685 as Bullish Momentum Intensifies
Cellectis CLLS Stock Dips 127 as Biotech Volatility Persists Key Support at 332 in Focus